Drug Profile
Research programme: cancer vaccines - Delta-Vir
Alternative Names: DVG 01Latest Information Update: 02 Jun 2016
Price :
$50
*
At a glance
- Originator Immunological and Oncological Centre in Cologne
- Class Cancer vaccines; Dendritic cell vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Glioblastoma
Most Recent Events
- 01 Sep 2013 Clinical trials in Glioblastoma in Germany (Parenteral)